Dynamic surveillance of tamoxifen‐resistance in ER‐positive breast cancer by CAIX‐targeted ultrasound imaging

Tamoxifen‐based hormone therapy is central for the treatment of estrogen receptor positive (ER(+)) breast cancer. However, the acquired tamoxifen resistance, typically co‐exists with hypoxia, remains a major challenge. We aimed to develop a non‐invasive, targeted ultrasound imaging approach to dynam...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ying, Chen, Xiaoyu, Zhou, ZhiWei, Li, Qing, Westover, Kenneth D., Wang, Meng, Liu, Junjun, Zhang, Sheng, Zhang, Jin, Xu, Bo, Wei, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131861/
https://www.ncbi.nlm.nih.gov/pubmed/32048471
http://dx.doi.org/10.1002/cam4.2878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131861/
https://www.ncbi.nlm.nih.gov/pubmed/32048471
http://dx.doi.org/10.1002/cam4.2878

Ejemplares similares